The Market Reports
Call: +1-631-407-1315 / +91-750-729-1479
Email: sales@themarketreports.com
Global Vero Cell Rabies Vaccines for Human Market Research Report 2025
Synopsis
The global Vero Cell Rabies Vaccines for Human market was valued at US$ 653 million in 2023 and is anticipated to reach US$ 1199.6 million by 2030, witnessing a CAGR of 0.6% during the forecast period 2024-2030.
Based on the culture medium, human rabies vaccines can be divided into vero cell vaccines, hamster kidney cell vaccines, chicken embryo cell vaccines and human diploid cell vaccines according to the culture medium. Developed countries in Europe and the United States mainly use human diploid cell vaccines , and China mainly uses second-generation vero cell vaccines.
This report aims to provide a comprehensive presentation of the global market for Vero Cell Rabies Vaccines for Human, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Vero Cell Rabies Vaccines for Human.
Report Scope
The Vero Cell Rabies Vaccines for Human market size, estimations, and forecasts are provided in terms of sales volume (K Units) and revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. This report segments the global Vero Cell Rabies Vaccines for Human market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Vero Cell Rabies Vaccines for Human manufacturers, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
Market Segmentation
By Company
Bharat Biotech
Sanofi-Pasteur
Chengda Bio
Prcmise
Zhuoyi Biological
Ningbo Rongan Biological
Indian Immunologicals
Segment by Type
Freeze-dried Powder
Liquid
Segment by Application
Pre-exposure Prophylaxis
Post-exposure Prophylaxis
Consumption by Region
North America
U.S.
Canada
Europe
Germany
France
U.K.
Italy
Russia
Asia-Pacific
China
Japan
South Korea
India
Australia
Taiwan
Indonesia
Thailand
Malaysia
Philippines
Vietnam
Latin America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
U.A.E
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by region, by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Detailed analysis of Vero Cell Rabies Vaccines for Human manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 3: Sales, revenue of Vero Cell Rabies Vaccines for Human in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and market size of each country in the world.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 7: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 8: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 9: The main points and conclusions of the report.
The global Vero Cell Rabies Vaccines for Human market was valued at US$ 653 million in 2023 and is anticipated to reach US$ 1199.6 million by 2030, witnessing a CAGR of 0.6% during the forecast period 2024-2030.
Based on the culture medium, human rabies vaccines can be divided into vero cell vaccines, hamster kidney cell vaccines, chicken embryo cell vaccines and human diploid cell vaccines according to the culture medium. Developed countries in Europe and the United States mainly use human diploid cell vaccines , and China mainly uses second-generation vero cell vaccines.
This report aims to provide a comprehensive presentation of the global market for Vero Cell Rabies Vaccines for Human, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Vero Cell Rabies Vaccines for Human.
Report Scope
The Vero Cell Rabies Vaccines for Human market size, estimations, and forecasts are provided in terms of sales volume (K Units) and revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. This report segments the global Vero Cell Rabies Vaccines for Human market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Vero Cell Rabies Vaccines for Human manufacturers, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
Market Segmentation
By Company
Bharat Biotech
Sanofi-Pasteur
Chengda Bio
Prcmise
Zhuoyi Biological
Ningbo Rongan Biological
Indian Immunologicals
Segment by Type
Freeze-dried Powder
Liquid
Segment by Application
Pre-exposure Prophylaxis
Post-exposure Prophylaxis
Consumption by Region
North America
U.S.
Canada
Europe
Germany
France
U.K.
Italy
Russia
Asia-Pacific
China
Japan
South Korea
India
Australia
Taiwan
Indonesia
Thailand
Malaysia
Philippines
Vietnam
Latin America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
U.A.E
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by region, by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Detailed analysis of Vero Cell Rabies Vaccines for Human manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 3: Sales, revenue of Vero Cell Rabies Vaccines for Human in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and market size of each country in the world.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 7: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 8: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 9: The main points and conclusions of the report.
Index1 Vero Cell Rabies Vaccines for Human Market Overview
1.1 Product Overview and Scope of Vero Cell Rabies Vaccines for Human
1.2 Vero Cell Rabies Vaccines for Human Segment by Type
1.2.1 Global Vero Cell Rabies Vaccines for Human Market Value Comparison by Type (2024-2030)
1.2.2 Freeze-dried Powder
1.2.3 Liquid
1.3 Vero Cell Rabies Vaccines for Human Segment by Application
1.3.1 Global Vero Cell Rabies Vaccines for Human Market Value by Application: (2024-2030)
1.3.2 Pre-exposure Prophylaxis
1.3.3 Post-exposure Prophylaxis
1.4 Global Vero Cell Rabies Vaccines for Human Market Size Estimates and Forecasts
1.4.1 Global Vero Cell Rabies Vaccines for Human Revenue 2019-2030
1.4.2 Global Vero Cell Rabies Vaccines for Human Sales 2019-2030
1.4.3 Global Vero Cell Rabies Vaccines for Human Market Average Price (2019-2030)
1.5 Assumptions and Limitations
2 Vero Cell Rabies Vaccines for Human Market Competition by Manufacturers
2.1 Global Vero Cell Rabies Vaccines for Human Sales Market Share by Manufacturers (2019-2024)
2.2 Global Vero Cell Rabies Vaccines for Human Revenue Market Share by Manufacturers (2019-2024)
2.3 Global Vero Cell Rabies Vaccines for Human Average Price by Manufacturers (2019-2024)
2.4 Global Vero Cell Rabies Vaccines for Human Industry Ranking 2022 VS 2023 VS 2024
2.5 Global Key Manufacturers of Vero Cell Rabies Vaccines for Human, Manufacturing Sites & Headquarters
2.6 Global Key Manufacturers of Vero Cell Rabies Vaccines for Human, Product Type & Application
2.7 Vero Cell Rabies Vaccines for Human Market Competitive Situation and Trends
2.7.1 Vero Cell Rabies Vaccines for Human Market Concentration Rate
2.7.2 The Global Top 5 and Top 10 Largest Vero Cell Rabies Vaccines for Human Players Market Share by Revenue
2.7.3 Global Vero Cell Rabies Vaccines for Human Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
2.8 Manufacturers Mergers & Acquisitions, Expansion Plans
3 Vero Cell Rabies Vaccines for Human Retrospective Market Scenario by Region
3.1 Global Vero Cell Rabies Vaccines for Human Market Size by Region: 2019 Versus 2023 Versus 2030
3.2 Global Vero Cell Rabies Vaccines for Human Global Vero Cell Rabies Vaccines for Human Sales by Region: 2019-2030
3.2.1 Global Vero Cell Rabies Vaccines for Human Sales by Region: 2019-2024
3.2.2 Global Vero Cell Rabies Vaccines for Human Sales by Region: 2025-2030
3.3 Global Vero Cell Rabies Vaccines for Human Global Vero Cell Rabies Vaccines for Human Revenue by Region: 2019-2030
3.3.1 Global Vero Cell Rabies Vaccines for Human Revenue by Region: 2019-2024
3.3.2 Global Vero Cell Rabies Vaccines for Human Revenue by Region: 2025-2030
3.4 North America Vero Cell Rabies Vaccines for Human Market Facts & Figures by Country
3.4.1 North America Vero Cell Rabies Vaccines for Human Market Size by Country: 2019 VS 2023 VS 2030
3.4.2 North America Vero Cell Rabies Vaccines for Human Sales by Country (2019-2030)
3.4.3 North America Vero Cell Rabies Vaccines for Human Revenue by Country (2019-2030)
3.4.4 U.S.
3.4.5 Canada
3.5 Europe Vero Cell Rabies Vaccines for Human Market Facts & Figures by Country
3.5.1 Europe Vero Cell Rabies Vaccines for Human Market Size by Country: 2019 VS 2023 VS 2030
3.5.2 Europe Vero Cell Rabies Vaccines for Human Sales by Country (2019-2030)
3.5.3 Europe Vero Cell Rabies Vaccines for Human Revenue by Country (2019-2030)
3.5.4 Germany
3.5.5 France
3.5.6 U.K.
3.5.7 Italy
3.5.8 Russia
3.6 Asia Pacific Vero Cell Rabies Vaccines for Human Market Facts & Figures by Country
3.6.1 Asia Pacific Vero Cell Rabies Vaccines for Human Market Size by Country: 2019 VS 2023 VS 2030
3.6.2 Asia Pacific Vero Cell Rabies Vaccines for Human Sales by Country (2019-2030)
3.6.3 Asia Pacific Vero Cell Rabies Vaccines for Human Revenue by Country (2019-2030)
3.6.4 China
3.6.5 Japan
3.6.6 South Korea
3.6.7 India
3.6.8 Australia
3.6.9 Taiwan
3.6.10 Indonesia
3.6.11 Thailand
3.6.12 Malaysia
3.6.13 Philippines
3.7 Latin America Vero Cell Rabies Vaccines for Human Market Facts & Figures by Country
3.7.1 Latin America Vero Cell Rabies Vaccines for Human Market Size by Country: 2019 VS 2023 VS 2030
3.7.2 Latin America Vero Cell Rabies Vaccines for Human Sales by Country (2019-2030)
3.7.3 Latin America Vero Cell Rabies Vaccines for Human Revenue by Country (2019-2030)
3.7.4 Mexico
3.7.5 Brazil
3.7.6 Argentina
3.8 Middle East and Africa Vero Cell Rabies Vaccines for Human Market Facts & Figures by Country
3.8.1 Middle East and Africa Vero Cell Rabies Vaccines for Human Market Size by Country: 2019 VS 2023 VS 2030
3.8.2 Middle East and Africa Vero Cell Rabies Vaccines for Human Sales by Country (2019-2030)
3.8.3 Middle East and Africa Vero Cell Rabies Vaccines for Human Revenue by Country (2019-2030)
3.8.4 Turkey
3.8.5 Saudi Arabia
3.8.6 U.A.E
4 Segment by Type
4.1 Global Vero Cell Rabies Vaccines for Human Sales by Type (2019-2030)
4.1.1 Global Vero Cell Rabies Vaccines for Human Sales by Type (2019-2024)
4.1.2 Global Vero Cell Rabies Vaccines for Human Sales by Type (2025-2030)
4.1.3 Global Vero Cell Rabies Vaccines for Human Sales Market Share by Type (2019-2030)
4.2 Global Vero Cell Rabies Vaccines for Human Revenue by Type (2019-2030)
4.2.1 Global Vero Cell Rabies Vaccines for Human Revenue by Type (2019-2024)
4.2.2 Global Vero Cell Rabies Vaccines for Human Revenue by Type (2025-2030)
4.2.3 Global Vero Cell Rabies Vaccines for Human Revenue Market Share by Type (2019-2030)
4.3 Global Vero Cell Rabies Vaccines for Human Price by Type (2019-2030)
5 Segment by Application
5.1 Global Vero Cell Rabies Vaccines for Human Sales by Application (2019-2030)
5.1.1 Global Vero Cell Rabies Vaccines for Human Sales by Application (2019-2024)
5.1.2 Global Vero Cell Rabies Vaccines for Human Sales by Application (2025-2030)
5.1.3 Global Vero Cell Rabies Vaccines for Human Sales Market Share by Application (2019-2030)
5.2 Global Vero Cell Rabies Vaccines for Human Revenue by Application (2019-2030)
5.2.1 Global Vero Cell Rabies Vaccines for Human Revenue by Application (2019-2024)
5.2.2 Global Vero Cell Rabies Vaccines for Human Revenue by Application (2025-2030)
5.2.3 Global Vero Cell Rabies Vaccines for Human Revenue Market Share by Application (2019-2030)
5.3 Global Vero Cell Rabies Vaccines for Human Price by Application (2019-2030)
6 Key Companies Profiled
6.1 Bharat Biotech
6.1.1 Bharat Biotech Corporation Information
6.1.2 Bharat Biotech Description and Business Overview
6.1.3 Bharat Biotech Vero Cell Rabies Vaccines for Human Sales, Revenue and Gross Margin (2019-2024)
6.1.4 Bharat Biotech Vero Cell Rabies Vaccines for Human Product Portfolio
6.1.5 Bharat Biotech Recent Developments/Updates
6.2 Sanofi-Pasteur
6.2.1 Sanofi-Pasteur Corporation Information
6.2.2 Sanofi-Pasteur Description and Business Overview
6.2.3 Sanofi-Pasteur Vero Cell Rabies Vaccines for Human Sales, Revenue and Gross Margin (2019-2024)
6.2.4 Sanofi-Pasteur Vero Cell Rabies Vaccines for Human Product Portfolio
6.2.5 Sanofi-Pasteur Recent Developments/Updates
6.3 Chengda Bio
6.3.1 Chengda Bio Corporation Information
6.3.2 Chengda Bio Description and Business Overview
6.3.3 Chengda Bio Vero Cell Rabies Vaccines for Human Sales, Revenue and Gross Margin (2019-2024)
6.3.4 Chengda Bio Vero Cell Rabies Vaccines for Human Product Portfolio
6.3.5 Chengda Bio Recent Developments/Updates
6.4 Prcmise
6.4.1 Prcmise Corporation Information
6.4.2 Prcmise Description and Business Overview
6.4.3 Prcmise Vero Cell Rabies Vaccines for Human Sales, Revenue and Gross Margin (2019-2024)
6.4.4 Prcmise Vero Cell Rabies Vaccines for Human Product Portfolio
6.4.5 Prcmise Recent Developments/Updates
6.5 Zhuoyi Biological
6.5.1 Zhuoyi Biological Corporation Information
6.5.2 Zhuoyi Biological Description and Business Overview
6.5.3 Zhuoyi Biological Vero Cell Rabies Vaccines for Human Sales, Revenue and Gross Margin (2019-2024)
6.5.4 Zhuoyi Biological Vero Cell Rabies Vaccines for Human Product Portfolio
6.5.5 Zhuoyi Biological Recent Developments/Updates
6.6 Ningbo Rongan Biological
6.6.1 Ningbo Rongan Biological Corporation Information
6.6.2 Ningbo Rongan Biological Description and Business Overview
6.6.3 Ningbo Rongan Biological Vero Cell Rabies Vaccines for Human Sales, Revenue and Gross Margin (2019-2024)
6.6.4 Ningbo Rongan Biological Vero Cell Rabies Vaccines for Human Product Portfolio
6.6.5 Ningbo Rongan Biological Recent Developments/Updates
6.7 Indian Immunologicals
6.6.1 Indian Immunologicals Corporation Information
6.6.2 Indian Immunologicals Description and Business Overview
6.6.3 Indian Immunologicals Vero Cell Rabies Vaccines for Human Sales, Revenue and Gross Margin (2019-2024)
6.4.4 Indian Immunologicals Vero Cell Rabies Vaccines for Human Product Portfolio
6.7.5 Indian Immunologicals Recent Developments/Updates
7 Industry Chain and Sales Channels Analysis
7.1 Vero Cell Rabies Vaccines for Human Industry Chain Analysis
7.2 Vero Cell Rabies Vaccines for Human Key Raw Materials
7.2.1 Key Raw Materials
7.2.2 Raw Materials Key Suppliers
7.3 Vero Cell Rabies Vaccines for Human Production Mode & Process
7.4 Vero Cell Rabies Vaccines for Human Sales and Marketing
7.4.1 Vero Cell Rabies Vaccines for Human Sales Channels
7.4.2 Vero Cell Rabies Vaccines for Human Distributors
7.5 Vero Cell Rabies Vaccines for Human Customers
8 Vero Cell Rabies Vaccines for Human Market Dynamics
8.1 Vero Cell Rabies Vaccines for Human Industry Trends
8.2 Vero Cell Rabies Vaccines for Human Market Drivers
8.3 Vero Cell Rabies Vaccines for Human Market Challenges
8.4 Vero Cell Rabies Vaccines for Human Market Restraints
9 Research Finding and Conclusion
10 Methodology and Data Source
10.1 Methodology/Research Approach
10.1.1 Research Programs/Design
10.1.2 Market Size Estimation
10.1.3 Market Breakdown and Data Triangulation
10.2 Data Source
10.2.1 Secondary Sources
10.2.2 Primary Sources
10.3 Author List
10.4 Disclaimer
List of TablesList of Tables
Table 1. Global Vero Cell Rabies Vaccines for Human Market Value Comparison by Type (2024-2030) & (US$ Million)
Table 2. Global Vero Cell Rabies Vaccines for Human Market Value Comparison by Application (2024-2030) & (US$ Million)
Table 3. Global Vero Cell Rabies Vaccines for Human Market Competitive Situation by Manufacturers in 2023
Table 4. Global Vero Cell Rabies Vaccines for Human Sales (K Units) of Key Manufacturers (2019-2024)
Table 5. Global Vero Cell Rabies Vaccines for Human Sales Market Share by Manufacturers (2019-2024)
Table 6. Global Vero Cell Rabies Vaccines for Human Revenue (US$ Million) by Manufacturers (2019-2024)
Table 7. Global Vero Cell Rabies Vaccines for Human Revenue Share by Manufacturers (2019-2024)
Table 8. Global Market Vero Cell Rabies Vaccines for Human Average Price (US$/Unit) of Key Manufacturers (2019-2024)
Table 9. Global Key Players of Vero Cell Rabies Vaccines for Human, Industry Ranking, 2022 VS 2023 VS 2024
Table 10. Global Key Manufacturers of Vero Cell Rabies Vaccines for Human, Manufacturing Sites & Headquarters
Table 11. Global Key Manufacturers of Vero Cell Rabies Vaccines for Human, Product Type & Application
Table 12. Global Key Manufacturers of Vero Cell Rabies Vaccines for Human, Date of Enter into This Industry
Table 13. Global Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 14. Global Vero Cell Rabies Vaccines for Human by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Vero Cell Rabies Vaccines for Human as of 2023)
Table 15. Manufacturers Mergers & Acquisitions, Expansion Plans
Table 16. Global Vero Cell Rabies Vaccines for Human Market Size by Region (US$ Million): 2019 VS 2023 VS 2030
Table 17. Global Vero Cell Rabies Vaccines for Human Sales by Region (2019-2024) & (K Units)
Table 18. Global Vero Cell Rabies Vaccines for Human Sales Market Share by Region (2019-2024)
Table 19. Global Vero Cell Rabies Vaccines for Human Sales by Region (2025-2030) & (K Units)
Table 20. Global Vero Cell Rabies Vaccines for Human Sales Market Share by Region (2025-2030)
Table 21. Global Vero Cell Rabies Vaccines for Human Revenue by Region (2019-2024) & (US$ Million)
Table 22. Global Vero Cell Rabies Vaccines for Human Revenue Market Share by Region (2019-2024)
Table 23. Global Vero Cell Rabies Vaccines for Human Revenue by Region (2025-2030) & (US$ Million)
Table 24. Global Vero Cell Rabies Vaccines for Human Revenue Market Share by Region (2025-2030)
Table 25. North America Vero Cell Rabies Vaccines for Human Revenue by Country: 2019 VS 2023 VS 2030 (US$ Million)
Table 26. North America Vero Cell Rabies Vaccines for Human Sales by Country (2019-2024) & (K Units)
Table 27. North America Vero Cell Rabies Vaccines for Human Sales by Country (2025-2030) & (K Units)
Table 28. North America Vero Cell Rabies Vaccines for Human Revenue by Country (2019-2024) & (US$ Million)
Table 29. North America Vero Cell Rabies Vaccines for Human Revenue by Country (2025-2030) & (US$ Million)
Table 30. Europe Vero Cell Rabies Vaccines for Human Revenue by Country: 2019 VS 2023 VS 2030 (US$ Million)
Table 31. Europe Vero Cell Rabies Vaccines for Human Sales by Country (2019-2024) & (K Units)
Table 32. Europe Vero Cell Rabies Vaccines for Human Sales by Country (2025-2030) & (K Units)
Table 33. Europe Vero Cell Rabies Vaccines for Human Revenue by Country (2019-2024) & (US$ Million)
Table 34. Europe Vero Cell Rabies Vaccines for Human Revenue by Country (2025-2030) & (US$ Million)
Table 35. Asia Pacific Vero Cell Rabies Vaccines for Human Revenue by Region: 2019 VS 2023 VS 2030 (US$ Million)
Table 36. Asia Pacific Vero Cell Rabies Vaccines for Human Sales by Region (2019-2024) & (K Units)
Table 37. Asia Pacific Vero Cell Rabies Vaccines for Human Sales by Region (2025-2030) & (K Units)
Table 38. Asia Pacific Vero Cell Rabies Vaccines for Human Revenue by Region (2019-2024) & (US$ Million)
Table 39. Asia Pacific Vero Cell Rabies Vaccines for Human Revenue by Region (2025-2030) & (US$ Million)
Table 40. Latin America Vero Cell Rabies Vaccines for Human Revenue by Country: 2019 VS 2023 VS 2030 (US$ Million)
Table 41. Latin America Vero Cell Rabies Vaccines for Human Sales by Country (2019-2024) & (K Units)
Table 42. Latin America Vero Cell Rabies Vaccines for Human Sales by Country (2025-2030) & (K Units)
Table 43. Latin America Vero Cell Rabies Vaccines for Human Revenue by Country (2019-2024) & (US$ Million)
Table 44. Latin America Vero Cell Rabies Vaccines for Human Revenue by Country (2025-2030) & (US$ Million)
Table 45. Middle East & Africa Vero Cell Rabies Vaccines for Human Revenue by Country: 2019 VS 2023 VS 2030 (US$ Million)
Table 46. Middle East & Africa Vero Cell Rabies Vaccines for Human Sales by Country (2019-2024) & (K Units)
Table 47. Middle East & Africa Vero Cell Rabies Vaccines for Human Sales by Country (2025-2030) & (K Units)
Table 48. Middle East & Africa Vero Cell Rabies Vaccines for Human Revenue by Country (2019-2024) & (US$ Million)
Table 49. Middle East & Africa Vero Cell Rabies Vaccines for Human Revenue by Country (2025-2030) & (US$ Million)
Table 50. Global Vero Cell Rabies Vaccines for Human Sales (K Units) by Type (2019-2024)
Table 51. Global Vero Cell Rabies Vaccines for Human Sales (K Units) by Type (2025-2030)
Table 52. Global Vero Cell Rabies Vaccines for Human Sales Market Share by Type (2019-2024)
Table 53. Global Vero Cell Rabies Vaccines for Human Sales Market Share by Type (2025-2030)
Table 54. Global Vero Cell Rabies Vaccines for Human Revenue (US$ Million) by Type (2019-2024)
Table 55. Global Vero Cell Rabies Vaccines for Human Revenue (US$ Million) by Type (2025-2030)
Table 56. Global Vero Cell Rabies Vaccines for Human Revenue Market Share by Type (2019-2024)
Table 57. Global Vero Cell Rabies Vaccines for Human Revenue Market Share by Type (2025-2030)
Table 58. Global Vero Cell Rabies Vaccines for Human Price (US$/Unit) by Type (2019-2024)
Table 59. Global Vero Cell Rabies Vaccines for Human Price (US$/Unit) by Type (2025-2030)
Table 60. Global Vero Cell Rabies Vaccines for Human Sales (K Units) by Application (2019-2024)
Table 61. Global Vero Cell Rabies Vaccines for Human Sales (K Units) by Application (2025-2030)
Table 62. Global Vero Cell Rabies Vaccines for Human Sales Market Share by Application (2019-2024)
Table 63. Global Vero Cell Rabies Vaccines for Human Sales Market Share by Application (2025-2030)
Table 64. Global Vero Cell Rabies Vaccines for Human Revenue (US$ Million) by Application (2019-2024)
Table 65. Global Vero Cell Rabies Vaccines for Human Revenue (US$ Million) by Application (2025-2030)
Table 66. Global Vero Cell Rabies Vaccines for Human Revenue Market Share by Application (2019-2024)
Table 67. Global Vero Cell Rabies Vaccines for Human Revenue Market Share by Application (2025-2030)
Table 68. Global Vero Cell Rabies Vaccines for Human Price (US$/Unit) by Application (2019-2024)
Table 69. Global Vero Cell Rabies Vaccines for Human Price (US$/Unit) by Application (2025-2030)
Table 70. Bharat Biotech Corporation Information
Table 71. Bharat Biotech Description and Business Overview
Table 72. Bharat Biotech Vero Cell Rabies Vaccines for Human Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 73. Bharat Biotech Vero Cell Rabies Vaccines for Human Product
Table 74. Bharat Biotech Recent Developments/Updates
Table 75. Sanofi-Pasteur Corporation Information
Table 76. Sanofi-Pasteur Description and Business Overview
Table 77. Sanofi-Pasteur Vero Cell Rabies Vaccines for Human Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 78. Sanofi-Pasteur Vero Cell Rabies Vaccines for Human Product
Table 79. Sanofi-Pasteur Recent Developments/Updates
Table 80. Chengda Bio Corporation Information
Table 81. Chengda Bio Description and Business Overview
Table 82. Chengda Bio Vero Cell Rabies Vaccines for Human Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 83. Chengda Bio Vero Cell Rabies Vaccines for Human Product
Table 84. Chengda Bio Recent Developments/Updates
Table 85. Prcmise Corporation Information
Table 86. Prcmise Description and Business Overview
Table 87. Prcmise Vero Cell Rabies Vaccines for Human Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 88. Prcmise Vero Cell Rabies Vaccines for Human Product
Table 89. Prcmise Recent Developments/Updates
Table 90. Zhuoyi Biological Corporation Information
Table 91. Zhuoyi Biological Description and Business Overview
Table 92. Zhuoyi Biological Vero Cell Rabies Vaccines for Human Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 93. Zhuoyi Biological Vero Cell Rabies Vaccines for Human Product
Table 94. Zhuoyi Biological Recent Developments/Updates
Table 95. Ningbo Rongan Biological Corporation Information
Table 96. Ningbo Rongan Biological Description and Business Overview
Table 97. Ningbo Rongan Biological Vero Cell Rabies Vaccines for Human Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 98. Ningbo Rongan Biological Vero Cell Rabies Vaccines for Human Product
Table 99. Ningbo Rongan Biological Recent Developments/Updates
Table 100. Indian Immunologicals Corporation Information
Table 101. Indian Immunologicals Description and Business Overview
Table 102. Indian Immunologicals Vero Cell Rabies Vaccines for Human Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 103. Indian Immunologicals Vero Cell Rabies Vaccines for Human Product
Table 104. Indian Immunologicals Recent Developments/Updates
Table 105. Key Raw Materials Lists
Table 106. Raw Materials Key Suppliers Lists
Table 107. Vero Cell Rabies Vaccines for Human Distributors List
Table 108. Vero Cell Rabies Vaccines for Human Customers List
Table 109. Vero Cell Rabies Vaccines for Human Market Trends
Table 110. Vero Cell Rabies Vaccines for Human Market Drivers
Table 111. Vero Cell Rabies Vaccines for Human Market Challenges
Table 112. Vero Cell Rabies Vaccines for Human Market Restraints
Table 113. Research Programs/Design for This Report
Table 114. Key Data Information from Secondary Sources
Table 115. Key Data Information from Primary Sources
List of Figures
Figure 1. Product Picture of Vero Cell Rabies Vaccines for Human
Figure 2. Global Vero Cell Rabies Vaccines for Human Market Value Comparison by Type (2024-2030) & (US$ Million)
Figure 3. Global Vero Cell Rabies Vaccines for Human Market Share by Type in 2023 & 2030
Figure 4. Freeze-dried Powder Product Picture
Figure 5. Liquid Product Picture
Figure 6. Global Vero Cell Rabies Vaccines for Human Market Value Comparison by Application (2024-2030) & (US$ Million)
Figure 7. Global Vero Cell Rabies Vaccines for Human Market Share by Application in 2023 & 2030
Figure 8. Pre-exposure Prophylaxis
Figure 9. Post-exposure Prophylaxis
Figure 10. Global Vero Cell Rabies Vaccines for Human Revenue, (US$ Million), 2019 VS 2023 VS 2030
Figure 11. Global Vero Cell Rabies Vaccines for Human Market Size (2019-2030) & (US$ Million)
Figure 12. Global Vero Cell Rabies Vaccines for Human Sales (2019-2030) & (K Units)
Figure 13. Global Vero Cell Rabies Vaccines for Human Average Price (US$/Unit) & (2019-2030)
Figure 14. Vero Cell Rabies Vaccines for Human Report Years Considered
Figure 15. Vero Cell Rabies Vaccines for Human Sales Share by Manufacturers in 2023
Figure 16. Global Vero Cell Rabies Vaccines for Human Revenue Share by Manufacturers in 2023
Figure 17. The Global 5 and 10 Largest Vero Cell Rabies Vaccines for Human Players: Market Share by Revenue in 2023
Figure 18. Vero Cell Rabies Vaccines for Human Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2019 VS 2023
Figure 19. Global Vero Cell Rabies Vaccines for Human Market Size by Region (US$ Million): 2019 VS 2023 VS 2030
Figure 20. North America Vero Cell Rabies Vaccines for Human Sales Market Share by Country (2019-2030)
Figure 21. North America Vero Cell Rabies Vaccines for Human Revenue Market Share by Country (2019-2030)
Figure 22. U.S. Vero Cell Rabies Vaccines for Human Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 23. Canada Vero Cell Rabies Vaccines for Human Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 24. Europe Vero Cell Rabies Vaccines for Human Sales Market Share by Country (2019-2030)
Figure 25. Europe Vero Cell Rabies Vaccines for Human Revenue Market Share by Country (2019-2030)
Figure 26. Germany Vero Cell Rabies Vaccines for Human Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 27. France Vero Cell Rabies Vaccines for Human Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 28. U.K. Vero Cell Rabies Vaccines for Human Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 29. Italy Vero Cell Rabies Vaccines for Human Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 30. Russia Vero Cell Rabies Vaccines for Human Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 31. Asia Pacific Vero Cell Rabies Vaccines for Human Sales Market Share by Region (2019-2030)
Figure 32. Asia Pacific Vero Cell Rabies Vaccines for Human Revenue Market Share by Region (2019-2030)
Figure 33. China Vero Cell Rabies Vaccines for Human Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 34. Japan Vero Cell Rabies Vaccines for Human Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 35. South Korea Vero Cell Rabies Vaccines for Human Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 36. India Vero Cell Rabies Vaccines for Human Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 37. Australia Vero Cell Rabies Vaccines for Human Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 38. Taiwan Vero Cell Rabies Vaccines for Human Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 39. Indonesia Vero Cell Rabies Vaccines for Human Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 40. Thailand Vero Cell Rabies Vaccines for Human Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 41. Malaysia Vero Cell Rabies Vaccines for Human Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 42. Philippines Vero Cell Rabies Vaccines for Human Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 43. Latin America Vero Cell Rabies Vaccines for Human Sales Market Share by Country (2019-2030)
Figure 44. Latin America Vero Cell Rabies Vaccines for Human Revenue Market Share by Country (2019-2030)
Figure 45. Mexico Vero Cell Rabies Vaccines for Human Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 46. Brazil Vero Cell Rabies Vaccines for Human Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 47. Argentina Vero Cell Rabies Vaccines for Human Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 48. Middle East & Africa Vero Cell Rabies Vaccines for Human Sales Market Share by Country (2019-2030)
Figure 49. Middle East & Africa Vero Cell Rabies Vaccines for Human Revenue Market Share by Country (2019-2030)
Figure 50. Turkey Vero Cell Rabies Vaccines for Human Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 51. Saudi Arabia Vero Cell Rabies Vaccines for Human Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 52. U.A.E Vero Cell Rabies Vaccines for Human Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 53. Global Sales Market Share of Vero Cell Rabies Vaccines for Human by Type (2019-2030)
Figure 54. Global Revenue Market Share of Vero Cell Rabies Vaccines for Human by Type (2019-2030)
Figure 55. Global Vero Cell Rabies Vaccines for Human Price (US$/Unit) by Type (2019-2030)
Figure 56. Global Sales Market Share of Vero Cell Rabies Vaccines for Human by Application (2019-2030)
Figure 57. Global Revenue Market Share of Vero Cell Rabies Vaccines for Human by Application (2019-2030)
Figure 58. Global Vero Cell Rabies Vaccines for Human Price (US$/Unit) by Application (2019-2030)
Figure 59. Vero Cell Rabies Vaccines for Human Value Chain
Figure 60. Vero Cell Rabies Vaccines for Human Production Process
Figure 61. Channels of Distribution (Direct Vs Distribution)
Figure 62. Distributors Profiles
Figure 63. Bottom-up and Top-down Approaches for This Report
Figure 64. Data Triangulation
Figure 65. Key Executives Interviewed
Published By : QY Research
Why ‘The Market Reports’
In Business:
Pre Sales Support:
Post Sales Support:
Turn Around Time:
Clients Served:
Clients Assisted:
Client Types:
Payment:
- Accept global payments [Credit Card / PayPal / Wire Transfer]
- Accept local payments in South Korea, Germany, China and India [Can pay in local currency]
Latest Life Science Market Reports
Payments Accepted From
Connect with us at
Complete Secure Website
